EP1967211A4 - Verfahren zur herstellung eines sich in der mundhöhle zersetzenden feststoffpräparats - Google Patents

Verfahren zur herstellung eines sich in der mundhöhle zersetzenden feststoffpräparats

Info

Publication number
EP1967211A4
EP1967211A4 EP20060843404 EP06843404A EP1967211A4 EP 1967211 A4 EP1967211 A4 EP 1967211A4 EP 20060843404 EP20060843404 EP 20060843404 EP 06843404 A EP06843404 A EP 06843404A EP 1967211 A4 EP1967211 A4 EP 1967211A4
Authority
EP
European Patent Office
Prior art keywords
oral cavity
solid preparation
producing solid
preparation disintegrating
disintegrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP20060843404
Other languages
English (en)
French (fr)
Other versions
EP1967211A1 (de
Inventor
Shigehiro Higuchi
Hiroshi Fukada
Toshihide Saito
Tetsuro Tabata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of EP1967211A1 publication Critical patent/EP1967211A1/de
Publication of EP1967211A4 publication Critical patent/EP1967211A4/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP20060843404 2005-12-28 2006-12-27 Verfahren zur herstellung eines sich in der mundhöhle zersetzenden feststoffpräparats Ceased EP1967211A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005379809 2005-12-28
PCT/JP2006/326022 WO2007074856A1 (ja) 2005-12-28 2006-12-27 口腔内崩壊性固形製剤の製造法

Publications (2)

Publication Number Publication Date
EP1967211A1 EP1967211A1 (de) 2008-09-10
EP1967211A4 true EP1967211A4 (de) 2009-12-30

Family

ID=38218077

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20060843404 Ceased EP1967211A4 (de) 2005-12-28 2006-12-27 Verfahren zur herstellung eines sich in der mundhöhle zersetzenden feststoffpräparats

Country Status (5)

Country Link
US (1) US8486450B2 (de)
EP (1) EP1967211A4 (de)
JP (1) JP5053865B2 (de)
CA (1) CA2634232C (de)
WO (1) WO2007074856A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
EP1854463A4 (de) 2005-03-03 2011-03-23 Takeda Pharmaceutical Zusammensetzung mit kontrollierter freisetzung
EP2012756A4 (de) * 2006-04-20 2013-01-23 Inventia Healthcare Private Ltd Zusammensetzungen mit mehreren einheiten
US8343548B2 (en) 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
US8343547B2 (en) * 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
US8519120B2 (en) 2006-08-08 2013-08-27 Shin-Etsu Chemical Co., Ltd. Methods for producing a low-substituted hydroxypropylcellulose powder
JP5366558B2 (ja) 2006-12-28 2013-12-11 武田薬品工業株式会社 口腔内崩壊性固形製剤
US8221747B2 (en) 2007-02-20 2012-07-17 Aptalis Pharma Limited Stable pancreatic enzyme compositions
EP2184056B1 (de) * 2007-08-27 2019-04-24 Asahi Kasei Kabushiki Kaisha Verfahren zur herstellung von tabletten mit kristalliner zellulose und granulaten
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
PE20091620A1 (es) * 2008-03-11 2009-11-12 Takeda Pharmaceutical Preparacion solida de desintegracion oral
JP2010070466A (ja) * 2008-09-16 2010-04-02 Kyoto Pharmaceutical Industries Ltd 口腔内崩壊錠
US8303868B2 (en) 2009-01-26 2012-11-06 Shin-Etsu Chemical Co., Ltd. Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
WO2012029838A1 (ja) * 2010-08-31 2012-03-08 協和発酵キリン株式会社 口腔内崩壊錠
EA029101B1 (ru) 2010-10-01 2018-02-28 Апталис Фарма Лимитид Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием
JP2014501226A (ja) * 2010-12-17 2014-01-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 直接圧縮可能なδ−マンニトールの調製方法
EP2665465A1 (de) * 2011-01-17 2013-11-27 Takeda Pharmaceutical Company Limited In der mundhöhle dispergierbare tablette
US9976171B2 (en) 2011-08-08 2018-05-22 Allergan Pharmaceuticals International Limited Method for dissolution testing of solid compositions containing digestive enzymes
WO2013125497A1 (ja) * 2012-02-20 2013-08-29 ニプロ株式会社 口腔内崩壊錠の製造方法
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
ES2784227T3 (es) 2013-08-09 2020-09-23 Allergan Pharmaceuticals Int Ltd Composición de enzimas digestivos adecuada para la administración entérica
CN103494784A (zh) * 2013-09-26 2014-01-08 天津市聚星康华医药科技有限公司 一种盐酸甲氯芬酯口腔崩解片及其制备方法
AU2015275860A1 (en) 2014-06-19 2016-11-03 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP6606287B2 (ja) 2016-07-27 2019-11-13 沢井製薬株式会社 口腔内崩壊錠添加用組成物
WO2018047789A1 (ja) * 2016-09-06 2018-03-15 沢井製薬株式会社 口腔内崩壊錠添加用組成物
CN109481690A (zh) * 2019-01-23 2019-03-19 谭淞文 一种新型微晶甘露醇药用辅料
GB2597577B (en) 2019-02-22 2023-09-20 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
CN113453662A (zh) 2019-02-22 2021-09-28 康特伦英国斯温顿捷迪斯有限公司 储存期间药物颗粒包衣材料的团聚最小化以稳定化药物产品的崩解时间
EP3923931A4 (de) * 2019-03-12 2022-10-26 Edenbridge Pharmaceuticals, LLC Im mund zerfallende tabletten mit glycopyrrolat und verfahren zur erhöhung der bioverfügbarkeit
JP7036856B2 (ja) * 2019-03-28 2022-03-15 日本ケミファ株式会社 口腔内崩壊錠
TW202220643A (zh) * 2020-07-27 2022-06-01 日商第一三共股份有限公司 含有米羅巴林苯磺酸鹽之口腔內崩散錠

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038960A1 (en) * 1996-04-16 1997-10-23 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
EP1203580A1 (de) * 1999-06-18 2002-05-08 Takeda Chemical Industries, Ltd. Rasch zerfallende feste zubereitungen
EP1488811A1 (de) * 2002-03-06 2004-12-22 Kyowa Hakko Kogyo Co., Ltd. Tabletten mit schneller auflösung in der mundhöhle

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
KR840002371A (ko) 1981-11-05 1984-06-25 귄터 미카엘, 헤르페르트 수키 치환된 벤즈 이미다졸의 제조방법
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPH072761B2 (ja) 1985-03-20 1995-01-18 不二パウダル株式会社 微結晶セルロ−ス球形顆粒及びその製造法
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
JPS62111980A (ja) 1985-11-08 1987-05-22 Otsuka Pharmaceut Co Ltd １ｈ−ベンズイミダゾ−ル誘導体
JPS62277322A (ja) 1986-02-13 1987-12-02 Takeda Chem Ind Ltd 安定化された腸溶性抗潰瘍固形組成物
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0674272B2 (ja) 1986-11-13 1994-09-21 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
JP2718945B2 (ja) 1987-06-17 1998-02-25 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
JP3163382B2 (ja) 1990-10-17 2001-05-08 武田薬品工業株式会社 ピリジン誘導体およびその製造法
JP2820829B2 (ja) 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
JPH05117268A (ja) 1991-10-22 1993-05-14 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物
JP3126683B2 (ja) 1996-04-16 2001-01-22 武田薬品工業株式会社 Ｄ−マンニトールおよびその製造法
US6328994B1 (en) 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
EP1561458B1 (de) 1998-07-28 2010-09-15 Takeda Pharmaceutical Company Limited Leicht zerfallende feste Zubereitung
ATE508725T1 (de) 2001-06-20 2011-05-15 Takeda Pharmaceutical Verfahren zur herstellung von tabletten
JP5138856B2 (ja) 2001-06-20 2013-02-06 武田薬品工業株式会社 錠剤の製造方法
JP5100391B2 (ja) 2005-10-05 2012-12-19 京都薬品工業株式会社 経口用組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038960A1 (en) * 1996-04-16 1997-10-23 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
EP1203580A1 (de) * 1999-06-18 2002-05-08 Takeda Chemical Industries, Ltd. Rasch zerfallende feste zubereitungen
EP1488811A1 (de) * 2002-03-06 2004-12-22 Kyowa Hakko Kogyo Co., Ltd. Tabletten mit schneller auflösung in der mundhöhle

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BURGER A ET AL: "Energy/temperature diagram and compression behavior of the polymorphs of D-mannitol", 1 January 2000, JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, PAGE(S) 457 - 468, ISSN: 0022-3549, XP003002443 *
See also references of WO2007074856A1 *

Also Published As

Publication number Publication date
WO2007074856A1 (ja) 2007-07-05
EP1967211A1 (de) 2008-09-10
CA2634232C (en) 2013-08-20
US20090148524A1 (en) 2009-06-11
US8486450B2 (en) 2013-07-16
JP5053865B2 (ja) 2012-10-24
CA2634232A1 (en) 2007-07-05
JPWO2007074856A1 (ja) 2009-06-04

Similar Documents

Publication Publication Date Title
EP1967211A4 (de) Verfahren zur herstellung eines sich in der mundhöhle zersetzenden feststoffpräparats
EP2233129A4 (de) In der mundhöhle zerfallende tablette und verfahren zu ihrer herstellung
HK1116410A1 (en) N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
HK1158990A1 (en) Tablet quickly disintegrating in the oral cavity and method for producing the same
EP1674083A4 (de) Tablette mit schneller auflösung in der mundhöhle
IL192098A (en) Preparations and Methods for Manufacturing Preparations
EP1952303B8 (de) Einschätzung des risikos zukünftiger knochenbrüche unter verwendung eines dreidimensionalen knochendichte-modells
EP1872711A4 (de) Fester kosmetischer stift und verfahren zu seiner herstellung
AP2008004491A0 (en) High viscocity ditutan gums and methods of producing
EP1729950A4 (de) Produktformwerkzeuge und verfahren zu deren herstellung
EP1951061A4 (de) Verfahren zur modifikation der textur eines präparats
EP1813678A4 (de) Verfahren zur herstellung von glykogen
ZA200710173B (en) Tygecycline and methods of preparing 9-nitrominocycline
EP1871150A4 (de) Verfahren zur herstellung eines supraleiter-beschleunigungsraumes
EP1997046A4 (de) Dreidimensionale modellierung des rachen-/mundhohlraums
SI1787526T1 (sl) Mešalec za proizvajanje sladoleda in podobnega
PL2091385T3 (pl) Miotły i sposoby wytwarzania mioteł
HK1100873A1 (en) Candy and process for producing the same
IL185627A0 (en) Alkyl-anilide producing method
PL1960321T3 (pl) Sposób wytwarzania elementów i konstrukcji z betonu
EP2037430A4 (de) Zahn für ein kieferzahnmodell und herstellungsverfahren dafür
EP1864684A4 (de) Künstlicher knochen und verfahren zu seiner herstellung
HK1164917A1 (en) Process of producing human type ii collagen ii
EP1834624A4 (de) Medizinische zusammensetzung und herstellungsverfahren dafür
EP1845979A4 (de) Verfahren und zusammensetzungen zur verringerung der speichelproduktion

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080609

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20091127

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4439 20060101ALI20091123BHEP

Ipc: A61K 9/20 20060101ALI20091123BHEP

Ipc: A61K 47/10 20060101AFI20070821BHEP

Ipc: C07D 401/12 20060101ALI20091123BHEP

17Q First examination report despatched

Effective date: 20100316

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20150325